Blood cancers

New predictor of outcomes in Burkitt lymphoma

The Burkitt Lymphoma International Prognostic Index (BL-IPI) is an effective risk-stratification tool for patients with the sporadic and immunodeficiency-related adult subtypes of the disease. A study, published in the Journal of Clinical Oncology, showed the BL-IPI is capable of identifying more low risk patients whose treatment might be de-escalated, an intermediate risk group, and high ...

Already a member?

Login to keep reading.

© 2021 the limbic